Maxwell Tawanda Chirehwa

8PUBLICATIONS
14CO-AUTHORS
Medical virologyEpidemiological methodsPharmacogenomicsInfant and child healthPsychopharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 06, 2023
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling.

M T Chirehwa, J E Resendiz-Galvan, R Court

|Jun 09, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.

Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius

|May 04, 2022
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.

Louvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf

|Aug 22, 2021
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.

Chishala Chabala, Anna Turkova, Anneke C Hesseling

|Jul 26, 2021
Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients.

Maxwell T Chirehwa, Richard Court, Mariana de Kock

|Aug 21, 2020
Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone.

Maxwell T Chirehwa, Richard Court, Mariana de Kock

Pageof 2

Frequent Collaborators

6 joint publications

Lubbe Wiesner

5 joint publications

Paolo Denti

4 joint publications

Gary Maartens

3 joint publications

Helen McIlleron